CIBC World Markets’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518K | Sell |
4,120
-487
| -11% | -$61.2K | ﹤0.01% | 781 |
|
|
2025
Q1 | $510K | Buy |
4,607
+38
| +0.8% | +$4.2K | ﹤0.01% | 999 |
|
|
2024
Q4 | $624K | Sell |
4,569
-1,295
| -22% | -$177K | ﹤0.01% | 677 |
|
|
2024
Q3 | $676K | Buy |
5,864
+498
| +9% | +$57.4K | ﹤0.01% | 649 |
|
|
2024
Q2 | $739K | Buy |
5,366
+1,343
| +33% | +$185K | ﹤0.01% | 620 |
|
|
2024
Q1 | $555K | Buy |
4,023
+1,303
| +48% | +$180K | ﹤0.01% | 702 |
|
|
2023
Q4 | $358K | Buy |
+2,720
| New | +$358K | ﹤0.01% | 676 |
|
|
2022
Q1 | – | Sell |
-50,000
| Closed | -$4.26M | – | 631 |
|
|
2021
Q4 | $4.26M | Buy |
+50,000
| New | +$4.26M | 0.02% | 285 |
|
|
2021
Q2 | – | Sell |
-10,087
| Closed | -$981K | – | 808 |
|
|
2021
Q1 | $981K | Buy |
+10,087
| New | +$981K | 0.01% | 576 |
|
|
2020
Q1 | – | Sell |
-109,300
| Closed | -$11.7M | – | 644 |
|
|
2019
Q4 | $11.7M | Buy |
+109,300
| New | +$11.7M | 0.08% | 222 |
|